VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 520 participants.
Also called NCT07516444
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 520 participants
- Sponsor
- VDyne, Inc.
- Registry
-
NCT07516444
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- United States
- Registry status
- Recruiting
Technical summary
Registry record NCT07516444. Randomized; single masking; primary purpose treatment. Start 2026-07-28 (actual); primary completion 2029-06 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- VDyne TriNova Transcatheter Tricuspid Valve Replacement Study to Evaluate Safety and Clinical Efficacy in Patients With Symptomatic Severe Tricuspid Valve Regurgitation (TRIVITA Pivotal Trial)
- Acronym
- TRIVITA
- Condition
- Tricuspid Valve Regurgitation
- Condition
- Tricuspid Valve Disease
- Condition
- Cardiovascular Diseases (CVD)
- Condition
- Heart Valve Diseases
- Condition
- Tricuspid Valve Insufficiency
- Condition
- Severe Heart Valve Disease
- Condition
- Randomized Controlled Trial (RCT)
- Condition
- Symptomatic Tricuspid Regurgitation
- Intervention (Device)
- Transcatheter Tricuspid Valve Replacement (TTVR) with VDyne TriNova System
- Intervention (Device)
- Transcatheter Tricuspid Valve Replacement (TTVR) with Edwards EVOQUE System
- Lead sponsor
- VDyne, Inc.
Record details
- Record id
cardio:ct-nct07516444- Content hash
4e3463bbbf872723b1285518800b04a6f458f204523e9d149b89f233c188d073